These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20012251)

  • 1. Regurgitation of my free lunch: the clinical toxicology and pharmaceutical company relationship.
    Cumpston KL
    J Med Toxicol; 2009 Dec; 5(4):257-8. PubMed ID: 20012251
    [No Abstract]   [Full Text] [Related]  

  • 2. The baby with the bathwater.
    Buyske J
    Arch Surg; 2010 Jun; 145(6):577. PubMed ID: 20575190
    [No Abstract]   [Full Text] [Related]  

  • 3. Sunshine Has Darkened my Worldview.
    Alward WL
    Am J Ophthalmol; 2017 Mar; 175():xii-xiii. PubMed ID: 28088286
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Madison hospitals say no to food, gifts, trinkets.
    Thompson CA
    Am J Health Syst Pharm; 2006 Dec; 63(24):2438, 2441. PubMed ID: 17158689
    [No Abstract]   [Full Text] [Related]  

  • 6. New Swiss guidelines aim to curb big pharma's influence.
    Hyde R
    Lancet; 2013 Feb; 381(9865):441-2. PubMed ID: 23405415
    [No Abstract]   [Full Text] [Related]  

  • 7. Extent of physician-pharmaceutical industry interactions in low- and middle-income countries: a systematic review.
    Fadlallah R; Alkhaled L; Brax H; Nasser M; Rajabbik MH; Nass H; Kahale LA; Akl EA
    Eur J Public Health; 2018 Apr; 28(2):224-230. PubMed ID: 29165586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan.
    Ichikawa I; Clayton EW
    Account Res; 2016; 23(4):245-53. PubMed ID: 26829657
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug representatives: giving you lunch or stealing your soul?
    Higgins SP
    Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
    De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
    PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unconscious conflict of interest: a Jewish perspective.
    Gold A; Appelbaum PS
    J Med Ethics; 2011 Jul; 37(7):402-5. PubMed ID: 20852304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time for the medical profession to act: new policies needed now on interactions between pharmaceutical companies and physicians.
    Greenland P
    Arch Intern Med; 2009 May; 169(9):829-31. PubMed ID: 19433693
    [No Abstract]   [Full Text] [Related]  

  • 13. Redefining the relationship: ethical prescribing in a pharmaceutical world.
    Wilson CR
    Can Fam Physician; 2008 Sep; 54(9):1341, 1342. PubMed ID: 18791108
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical students' attitudes to and contact with the pharmaceutical industry: a survey at eight German university hospitals.
    Lieb K; Koch C
    Dtsch Arztebl Int; 2013 Sep; 110(35-36):584-90. PubMed ID: 24078838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' attitudes about gifts to physicians from pharmaceutical companies.
    Blake RL; Early EK
    J Am Board Fam Pract; 1995; 8(6):457-64. PubMed ID: 8585404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
    Barnes RK
    Med J Aust; 2010 Mar; 192(5):294-5. PubMed ID: 20306549
    [No Abstract]   [Full Text] [Related]  

  • 17. Physician attitudes toward industry: a view across the specialties.
    Korenstein D; Keyhani S; Ross JS
    Arch Surg; 2010 Jun; 145(6):570-7. PubMed ID: 20566978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical students protest perks from drug companies.
    Opar A
    Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
    [No Abstract]   [Full Text] [Related]  

  • 19. A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.
    Lieb K; Brandtönies S
    Dtsch Arztebl Int; 2010 Jun; 107(22):392-8. PubMed ID: 20574555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industry relationships with physicians under scrutiny.
    Beller GA
    J Nucl Cardiol; 2008; 15(6):737-8. PubMed ID: 18984446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.